The Eylea Market has been witnessing significant transformation due to advancements in ophthalmic treatments and an increase in age-related macular degeneration (AMD) cases. Eylea (aflibercept) is an anti-VEGF therapy used widely in the treatment of wet AMD, diabetic macular edema (DME), and retinal vein occlusion (RVO). Its effectiveness in reducing vision loss and improving visual a... https://www.marketresearchfuture.com/reports/eylea-market-21316